Zebrafish Pseudomonas Infection Models

Introduction Model Details Phenotypic Evaluation Applications Study Examples

Introduction

Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that causes acute and chronic infections in humans and animals. It is frequently associated with pneumonia, wound infection, burn infection, urinary tract infection, bloodstream infection, and chronic airway infection in patients with cystic fibrosis. Key pathological features include bacterial adhesion, tissue invasion, biofilm formation, toxin secretion, excessive inflammation, and resistance to host clearance. Patients with cystic fibrosis, severe burns, implanted devices, immunosuppression, or prolonged hospitalization are particularly vulnerable. The increasing prevalence of multidrug-resistant P. aeruginosa has made this pathogen a major clinical and public health concern.

Current treatment relies mainly on antibiotics, often in combination regimens. However, intrinsic drug resistance, biofilm-associated tolerance, strain heterogeneity, and limited in vivo models for rapid efficacy testing remain significant challenges. Zebrafish Pseudomonas infection models provide a practical vertebrate system to study bacterial virulence, innate immune response, phagocyte-pathogen interaction, cystic fibrosis-related susceptibility, wound infection, and anti-Pseudomonas therapeutic activity in vivo.

Why Zebrafish?

Real-Time Imaging: Transparent embryos allow real-time imaging of infection progression.
Conserved Innate Immunity: Conserved innate immunity supports host-pathogen studies.
Flexible Infection Routes: Microinjection and immersion methods enable flexible infection routes.
Therapeutic Screening: Suitable for antimicrobial, phage, and immunomodulator screening.
Reporter Lines: Reporter lines support neutrophil and macrophage analysis.

Available Zebrafish Disease Models

Our platform covers systemic infection, innate immunity, cystic fibrosis, and wound infection configurations:

Model Name	Induction Method	Features
Zebrafish Pseudomonas aeruginosa Acute Systemic Infection Model	Live P. aeruginosa strains, such as PA14 or PAO1, are introduced into zebrafish embryos or larvae by microinjection into defined sites, including the hindbrain ventricle, yolk sac, or circulation.	A widely used model for acute bacterial infection, survival analysis, bacterial burden quantification, and virulence-factor assessment.
Zebrafish P. aeruginosa Innate Immunity Model	Embryos or larvae are infected with fluorescent or non-fluorescent P. aeruginosa, often combined with neutrophil or macrophage reporter lines.	Enables visualization of phagocyte recruitment, bacterial clearance, inflammatory signaling, and host susceptibility.
Zebrafish Cystic Fibrosis-Associated P. aeruginosa Infection Model	cftr-deficient or CFTR-disrupted zebrafish are challenged with P. aeruginosa to evaluate infection susceptibility and therapeutic response.	Useful for cystic fibrosis infection research, phage therapy evaluation, antibiotic testing, and host defense studies.
Zebrafish Wound Infection Model	Zebrafish embryos or larvae are wounded and then exposed to P. aeruginosa by immersion or local infection.	Models wound colonization, intracellular persistence, inflammation, antibiotic tolerance, and anti-infective efficacy.

Phenotypic Evaluation

Innate Immune Response

Neutrophil and macrophage recruitment
Phagocytosis and intracellular bacterial persistence
Inflammatory cytokines, such as il1b, tnfa, il6, and cxcl8
ROS and oxidative stress markers

Therapeutic Efficacy and Safety

Survival rescue after antibiotic, phage, or compound treatment
Reduction of bacterial burden
Dose-response and treatment-window evaluation
Developmental toxicity and general safety endpoints

Disease Severity and Survival

Survival rate and Kaplan–Meier analysis
Dose-response or LD50 assessment
Edema, tissue damage, and gross morphology scoring
Locomotor activity or behavioral impairment

Bacterial Burden and Clearance

CFU quantification from larvae or dissected tissues
Fluorescent bacterial load imaging
Tissue dissemination analysis
Pathogen clearance after treatment

Key Applications

Anti-Pseudomonas Drug Discovery: In vivo screening and validation of antibiotics, antimicrobial peptides, natural products, and small molecules.
Phage Therapy Evaluation: Assessment of prophylactic or therapeutic bacteriophage efficacy against P. aeruginosa infection.
Cystic Fibrosis Infection Research: Modeling increased susceptibility to P. aeruginosa in CFTR-deficient zebrafish.
Virulence Mechanism Studies: Evaluation of type III secretion, quorum sensing, biofilm-associated factors, and strain-specific pathogenicity.
Innate Immunity Studies: Analysis of neutrophil and macrophage responses, inflammatory signaling, and bacterial clearance.
Wound Infection and Persistence Studies: Investigation of tissue colonization, intracellular persistence, and antibiotic tolerance in vivo.

Study Examples

Zebrafish model reveals the role of type III secretion in phagocyte-pathogen interaction. The authors developed a systemic P. aeruginosa infection model in optically transparent zebrafish embryos. Bacteria were injected into embryos, allowing live imaging of interactions between bacteria and innate immune cells. The study focused on the type III secretion system and its effect on phagocyte behavior, bacterial control, and infection severity. Results showed that P. aeruginosa virulence is strongly shaped by its interaction with phagocytes, supporting the use of zebrafish for visualizing early immune-pathogen dynamics in vivo.

The P. aeruginosa type III secretion system alters phagocyte interactions during systemic zebrafish infection Fig. 1. The P. aeruginosa type III secretion system alters phagocyte interactions during systemic zebrafish infection (Brannon MK, Davis JM, et al., 2009).

CFTR function contributes to zebrafish resistance against P. aeruginosa infection. This study used zebrafish to investigate the relationship between CFTR function and susceptibility to P. aeruginosa. By disrupting zebrafish cftr function and challenging embryos with P. aeruginosa, the authors assessed bacterial burden and survival outcomes. The work showed that impaired CFTR function increased susceptibility to P. aeruginosa infection, consistent with clinical observations in cystic fibrosis. The model is relevant for studying cystic fibrosis-associated infection biology and for evaluating anti-Pseudomonas interventions in a vertebrate host.

Fig. 2. CFTR-deficient zebrafish show increased susceptibility to P. aeruginosa infection (Phennicie RT, Sullivan MJ, et al., 2010).

Advance Your Anti-Pseudomonas Research with Validated Zebrafish Infection Models

Our zebrafish CRO platform supports Pseudomonas aeruginosa model establishment, bacterial challenge, survival analysis, CFU quantification, live imaging, immune profiling, antibiotic efficacy testing, phage therapy evaluation, and customized study design for host-pathogen interaction research.

Contact Our Scientists

References

Brannon MK, Davis JM, et al. Pseudomonas aeruginosa Type III secretion system interacts with phagocytes to modulate systemic infection of zebrafish embryos. Cellular Microbiology 11(5), 755–768 (2009). doi:10.1111/j.1462-5822.2009.01288.x.
Phennicie RT, Sullivan MJ, et al. Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator. Infection and Immunity 78(11), 4542–4550 (2010). doi:10.1128/IAI.00302-10.

For research use only. Not intended for any clinical use.